Steve Lissner's topic on approval process and fast track status (Europe vs. US) for cancer drugs. "A MUST READ"
Could it be that INOs partnership with Roche (European company), is even more valuable because we could get fast track approval in Europe much quicker than in US????? Dr. Kim is way smarter than any one thinks!!